Abstract
To ascertain the efficacy of systemic cyclosporin therapy in the management of scleritis we performed an open, uncontrolled study of the use of this drug in severe refractory disease. Five of seven patients whose disease had previously been poorly controlled with a combination of corticosteroids and immunosuppressive drugs responded to cyclosporin therapy (10 mg/kg/day). Systemic side effects occurred in all but one patient, with tremor, hirsutism, hypertension, and raised serum creatinine being common. Recurrence of disease activity on decreasing the dosage of cyclosporin was frequent. The results indicate that cyclosporin is a useful additional drug in the treatment of severe scleritis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Foster C. S., Forstot S. L., Wilson L. A. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology. 1984 Oct;91(10):1253–1263. doi: 10.1016/s0161-6420(84)34160-4. [DOI] [PubMed] [Google Scholar]
- McCluskey P., Wakefield D. Current concepts in the management of scleritis. Aust N Z J Ophthalmol. 1988 Aug;16(3):169–176. doi: 10.1111/j.1442-9071.1988.tb01206.x. [DOI] [PubMed] [Google Scholar]
- McCluskey P., Wakefield D. Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol. 1987 Jun;105(6):793–797. doi: 10.1001/archopht.1987.01060060079037. [DOI] [PubMed] [Google Scholar]
- Meyer P. A., Watson P. G., Franks W., Dubord P. 'Pulsed' immunosuppressive therapy in the treatment of immunologically induced corneal and scleral disease. Eye (Lond) 1987;1(Pt 4):487–495. doi: 10.1038/eye.1987.73. [DOI] [PubMed] [Google Scholar]
- Nussenblatt R. B., Palestine A. G. Cyclosporine: immunology, pharmacology and therapeutic uses. Surv Ophthalmol. 1986 Nov-Dec;31(3):159–169. doi: 10.1016/0039-6257(86)90035-4. [DOI] [PubMed] [Google Scholar]
- Shevach E. M. The effects of cyclosporin A on the immune system. Annu Rev Immunol. 1985;3:397–423. doi: 10.1146/annurev.iy.03.040185.002145. [DOI] [PubMed] [Google Scholar]
- Wakefield D., Robinson L. P. Cyclosporin therapy in Mooren's ulcer. Br J Ophthalmol. 1987 Jun;71(6):415–417. doi: 10.1136/bjo.71.6.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watson P. G. Doyne Memorial Lecture, 1982. The nature and the treatment of scleral inflammation. Trans Ophthalmol Soc U K. 1982 Jul;102(Pt 2):257–281. [PubMed] [Google Scholar]